Is Oric Pharmaceuticals Inc (ORIC) overvalued? · $893.4M cap
Oric Pharmaceuticals Inc (ORIC) is a biotechnology company listed on NASDAQ.
This page asks whether Oric Pharmaceuticals Inc (ORIC) looks expensive on cached numbers — not a short thesis.
No cached income statement for ORIC, so there is no earnings base to call rich or cheap.
ORIC currently screens at market cap $893.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ORIC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ORIC stock page for the full model, not this heading.
Not investment advice.